Showing results (411-420 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|December 1, 1992
Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancerA Hirvonen, K Husgafvel-Pursiainen, S Anttila, et al.Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.Pharmacogenetics|February 1, 1992
Effects of ethanol, dexamethasone and RU 486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao)I de Waziers, J Bouguet, P H Beaune, et al.Pharmacogenetics|February 1, 1992
Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsT Andersson, C G Regårdh, Y C Lou, et al.Pharmacogenetics|February 1, 1992
Variability of acetaminophen metabolism in Caucasians and OrientalsM Patel, B K Tang, W KalowPharmacogenetics|January 16, 1998
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 alleleJ Thompson, N Thomas, A Singleton, et al.Pharmacogenetics|March 25, 1998
Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German populationE U Griese, U M Zanger, U Brudermanns, et al.Pharmacogenetics|March 25, 1998
Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patientsM J Harris, M Coggan, L Langton, et al.Pharmacogenetics|March 25, 1998
Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probeN C Hughes, S A Janezic, K L McQueen, et al.Pageof 83